Teva Pharmaceutical Industries (TEVA) Net Income Growth (5y) (2014 - 2026)
Teva Pharmaceutical Industries (TEVA) Net Income Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -36.52% |
| Mar 31, 2026 | 35.17% |
| Dec 31, 2025 | 24.36% |
| Sep 30, 2025 | 15.96% |
| Jun 30, 2025 | 39.60% |
| Mar 31, 2025 | 53.28% |
| Dec 31, 2024 | -40.31% |
| Sep 30, 2024 | -5.34% |
| Jun 30, 2024 | -5.48% |
| Mar 31, 2024 | 49.95% |
| Dec 31, 2023 | 11.17% |
| Sep 30, 2023 | 19.20% |
| Jun 30, 2023 | -39.13% |
| Mar 31, 2023 | -17.18% |
| Dec 31, 2022 | 35.27% |
| Sep 30, 2022 | -36.36% |
| Jun 30, 2022 | 45.82% |
| Mar 31, 2022 | -28.73% |
| Dec 31, 2021 | 11.55% |
| Sep 30, 2021 | -5.59% |